Calcium Supplementation and Incident Kidney Stone Risk: A Systematic Review

Journal of the American College of Nutrition

Volumn 27, Issue 5, 2008, Pages 519-527

  Heaney, Robert P ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Calcium intake; Calcium supplements; Kidney stones

Indexed keywords

CALCIUM; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID; PLACEBO; RISEDRONIC ACID;

CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; FEMALE; HUMAN; INCIDENCE; NEPHROLITHIASIS; PATHOPHYSIOLOGY; POSTMENOPAUSE; REVIEW; RISK FACTOR; BODY MASS; CALCIUM INTAKE; CLINICAL TRIAL; DRUG EFFICACY; ENVIRONMENTAL FACTOR; HYPERCALCIURIA; HYPEROXALURIA; LOW DRUG DOSE; MEDICAL LITERATURE; OBSERVATIONAL STUDY; ONLINE ANALYSIS; OSTEOPOROSIS; RISK ASSESSMENT; VITAMIN SUPPLEMENTATION;

CALCIUM; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INCIDENCE; KIDNEY CALCULI; NEPHROLITHIASIS; POSTMENOPAUSE; RISK FACTORS;

EID: 58149390415     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2008.10719734     Document Type: Article

References (49)

1. Rodgers A: Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation. J Am Soc Nephrol 10 (Suppl 14): S351-S354, 1999.
2. Hess B, Tiselius H-G: Physical-chemical processes in kidney stone formation. In Coe FL, Favus MJ (eds): –Disorders of Bone & Mineral Metabolism,— 2nd ed. Philadelphia: Lippincott Williams & Wilkins, pp. 619-628, 2002.
3. Curhan GC, Willett WC, Rimm EB, Stampfer MJ: A prospective study of dietary calcium and other nutrients and the risk of asymptomatic kidney stones. N Engl J Med 328: 833-838, 1993.
4. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346: 77-84, 2002.
5. NIH Consensus Conference: Optimal Calcium Intake. J Am Med Assoc 272: 1942-1948, 1994.
6. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SAA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanik ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D: Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354: 669-683, 2006.
7. Chandhoke PS: Metabolic abnormalities and medical management of calcium oxalate nephrolithiasis. Minerva Urol Nefrol 67: 9-16, 2005.
8. Coe FL, Parks JH, Favus MJ: Diet and calcium: the end of an era? Ann Intern Med 126: 553-555, 1997.
9. Lemann J Jr: Calcium and phosphate metabolism: An overview in health and in calcium formers. In Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds): –Kidney Stones Medical and Surgical Management.— Philadelphia: Lippincott-Raven, pp. 259-288, 1996.
10. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 71, 1996.
11. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC: Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63: 1817-1823, 2003.
12. Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones. Kidney Int 73: 207-212, 2008.
13. Scales CD Jr, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA, Preminger GM: Changing gender prevalence of stone disease. J Urol 177: 979-982, 2007.
14. Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT: Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int 16: 624-631, 1979.
15. Lieske JC, PeñadelaVega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho K-L, Gettman MT: Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69: 760-764, 2006.
16. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ: Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126: 497-504, 1997.
17. Curhan GC, Willett WC, Knight EL, Stampfer MJ: Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med 164: 885-891, 2004.
18. Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, Garnero P, Meunier JP: Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal ofsecondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 13: 257-264, 2002.
19. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ: Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327: 1637-1642, 1992.
20. Brazier M, Grados F, Kamel S, Mathieu M, Morel A, Maamer M, Sebert JL, Fardellone P: Clinical and laboratory safety of one year's use of a combination calcium vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 27: 1885-1893, 2005.
21. Grant AM, Avenell A, Campbell MK, McDonald AM, McPherson GC, Anderson FH, Cooper C, Francis RM, Donaldson C, Gillespie WJ, Robinson CM, Torgerson TJ, Wallace WA: Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or Vitamin D, RECORD); a randomized placebo-controlled trial. Lancet 365: 1621-1628, 2005.
22. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337: 670-676, 1997.
23. Peacock M, Liu G, Carey M, McClintock R, Ambrosius W, Hui S, Johnston CC Jr: Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 85: 3011-3019, 2000.
24. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ: Longterm effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 98: 331-335, 1995.
25. Recker RR, Hinders S, Davies KM, Heaney RP, Stegman MR, Lappe JM, Kimmel DB: Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 11: 1961-1966, 1996.
26. Riggs BL, O'Fallon WM, Muhs J, O'Connor MK, Kumar R, Melton LJ III: Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 13: 168-174, 1998.
27. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ: Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 328: 460-464, 1993.
28. Reid IR, Mason B, Horne A, Ames R, Reid HE, Bava U, Bolland MJ, Gamble GD: Randomized controlled trial of calcium in healthy older women. Am J Med 119: 777-785, 2006.
29. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP: Vitamin D and calcium supplementation reduces cancer risk. Am J Clin Nutr 85: 1586-1591, 2007.
30. Chevalley T, Rizzoli R, Nydegger V, Slosman D, Rapin R-H, Michel J-P, Vassey H, Bonjour J-P: Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos Int 4: 245-252, 1994.
31. Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray TJ, Baverstock M, Birks Y, Dumville J, Francis RM, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ: Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. Br Med J 330: 1003-1006, 2005.
32. Nelson ME, Fisher EC, Dilmanian FA, Dallal GE, Evans WJ: A 1-y walking program and increased dietary calcium in postmenopausal women: effects on bone. Am J Clin Nutr 53: 1304-1311, 1991.
33. Smith EL, Gilligan C, Smith PE, Sempos CT: Calcium supplementation and bone loss in middle-aged women. Am J Clin Nutr 50: 833-842, 1989.
34. Harwood RH, Sahota O, Gaynor K, Masud T, Hosking DJ: A randomized, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing 33: 45-51, 2004.
35. Prince R, Devine A, Dick I, Criddle A, Kerr D, Kent N, Price R, Randell A: The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women. J Bone Miner Res 10: 1068-1075, 1995.
36. Aloia JF, Vaswani A, Yeh JK, Ross PL, Flaster E, Dilmanian FA: Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 120: 97-103, 1994.
37. Elders PJ, Netelenbos JC, Lips P, van Ginkel FC, Khoe E, Leeuwenkamp OR, Hackeng WH, van der Stelt PF: Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 73: 533-540, 1991.
38. Strause L, Saltman P, Smith KT, Bracker M, Andon MB: Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 124: 1060-1064, 1994.
39. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S: A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323: 878-883, 1990.
40. Riis B, Thomsen K, Christiansen C: Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med 316: 173-177, 1987.
41. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, DerSimonian R, Esterlitz JR, Raymond EG: Trial of calcium to prevent preeclampsia. N Engl J Med 337: 69-76, 1997.
42. Women's Health Initiative 2007 Annual Progress Report. Prepared by WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, WA. Ross Prentice, Principal Investigator.
43. Sowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson B: Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures. Am J Epidemiol 147: 914-920, 1998.
44. Jackson RD, LaCroix AZ, Cauley JA, McGowan J: The Women's Health Initiative Calcium-Vitamin D Trial: Overview and baseline characteristics of participants. Ann Epidemiol 13: S98-S106, 2003.
45. U.S. Department of Health and Human Services: –Bone Health and Osteoporosis: A Report of the Surgeon General.— Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General, 2004.
46. U.S. Department of Health and Human Services and U.S. Department of Agriculture: –Dietary Guidelines for Americans, 2005,— 6th Ed. Washington, DC: U.S. Government Printing Office, 2005.
47. van der Voort DJ, Geusens PP, Dinant GJ: Risk factors for osteoporosis related to their outcome: Fractures. Osteoporos Int 12: 639-638, 2001.
48. Barger-Lux MJ, Dowell MS, Heaney RP: A relationship between body composition and calcium absorption efficiency. J Bone Miner Res 19 (Suppl 1): S302, 2004.
49. Rosen CJ. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med 348: 1503-1504, 2003.